Support WBURFDA Approves Esketamine Nasal Spray For Hard-To-Treat DepressionPlay03:40Download AudioJon HamiltonMarch 05, 2019 ShareSpravato, the brand name for esketamine, a newly approved option for treatment-resistant depression. (Janssen Pharmaceutica)
